Article Information
History
- September 23, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 23, 2020 - 03:18).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Sawako Hibino, MD Ph.D.1,
- Kazutaka Hayashida, MD Ph.D.2,*,
- Andrew C Ahn, MD, MPH3 and
- Yasutaka Hayashida, MD Ph.D.1,*
- 1Y’s Science Clinic Hiroo, Medical Corporation Koshikai, Tokyo, Japan
- 2Division of pulmonary medicine, Boston Children’s Hospital, Boston. USA
- 3Division of General Medicine and Primary Care, Beth Israel Deaconess Medical School, Boston, USA
- ↵*Corresponding Authors; Kazutaka Hayashida, MD, Ph.D. Division of Pulmonary Medicine, Boston Children’s Hospital, 300 Longwood Ave, Boston MA 02115, (kazutaka.hayashida{at}childrens.harvard.edu), Yasutaka Hayashida, MD, Ph.D. Y’s Science Clinic Hiroo, Medical Corporation Koshikai, 5-15-27 Minami-Azabu, Minato-ku, Tokyo, Japan, (pandarinda{at}gmail.com)
Posted September 23, 2020.
Dynamic Change of COVID-19 Seroprevalence among Asymptomatic Population in Tokyo during the Second Wave
